SG42817A1 - Benzopyrans - Google Patents

Benzopyrans

Info

Publication number
SG42817A1
SG42817A1 SG1995002213A SG1995002213A SG42817A1 SG 42817 A1 SG42817 A1 SG 42817A1 SG 1995002213 A SG1995002213 A SG 1995002213A SG 1995002213 A SG1995002213 A SG 1995002213A SG 42817 A1 SG42817 A1 SG 42817A1
Authority
SG
Singapore
Prior art keywords
disease
compounds
motility
asthma
hypertension
Prior art date
Application number
SG1995002213A
Other languages
English (en)
Inventor
Alexander Roderick D Mackenzie
Sandra Marina Dr Monaghan
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of SG42817A1 publication Critical patent/SG42817A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1995002213A 1993-08-04 1994-07-18 Benzopyrans SG42817A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939316111A GB9316111D0 (en) 1993-08-04 1993-08-04 Benzopyrans

Publications (1)

Publication Number Publication Date
SG42817A1 true SG42817A1 (en) 1997-10-17

Family

ID=10739921

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995002213A SG42817A1 (en) 1993-08-04 1994-07-18 Benzopyrans

Country Status (28)

Country Link
US (2) US5912244A (de)
EP (1) EP0712398B1 (de)
JP (1) JP2871098B2 (de)
KR (1) KR0175532B1 (de)
CN (1) CN1128536A (de)
AT (1) ATE152716T1 (de)
AU (1) AU684817B2 (de)
CA (1) CA2168563C (de)
CO (1) CO4230234A1 (de)
CZ (1) CZ281853B6 (de)
DE (1) DE69403084T2 (de)
DK (1) DK0712398T3 (de)
EC (1) ECSP941140A (de)
EG (1) EG20525A (de)
ES (1) ES2102870T3 (de)
FI (1) FI960487A0 (de)
GB (1) GB9316111D0 (de)
GR (1) GR3023521T3 (de)
HU (1) HUT75120A (de)
IL (1) IL110488A (de)
NO (1) NO960441L (de)
NZ (1) NZ271344A (de)
PE (1) PE56894A1 (de)
PL (1) PL312788A1 (de)
SG (1) SG42817A1 (de)
TW (1) TW333532B (de)
WO (1) WO1995004730A1 (de)
ZA (1) ZA945774B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
ATE240950T1 (de) * 1996-06-07 2003-06-15 Univ Vanderbilt Dihydrobenzopyran und ähnliche verbindungen verwendbar als antientzündungsmittel
US6333352B1 (en) * 2000-04-05 2001-12-25 Mimicking Man Manually, Inc. Method of treating benign positional vertigo
DK1818325T3 (da) * 2001-04-16 2010-05-31 Schering Corp 3,4-di-substituerede cyklobuten-1,2-dioner som CXC-chemokin receptorligander
WO2003029238A1 (en) * 2001-10-04 2003-04-10 Wyeth Chroman derivatives as 5-hydroxytryptamine-6 ligands
WO2004043424A1 (en) * 2002-11-12 2004-05-27 Warner-Lambert Company Llc Method of stimulating hair growth using benzopyrans
BRPI0507669A (pt) * 2004-02-12 2007-07-17 Warner Lambert Co método para estimular crescimento de cabelo
US20090110892A1 (en) * 2004-06-30 2009-04-30 General Electric Company System and method for making a graded barrier coating
CA2573718A1 (en) * 2004-07-16 2006-01-26 Warner-Lambert Company Llc Hair growth promoting agents
JP2008506767A (ja) * 2004-07-19 2008-03-06 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 発毛を刺激する製剤
RU2396266C2 (ru) * 2004-12-21 2010-08-10 Ф. Хоффманн-Ля Рош Аг Производные хромана и их применения при лечении заболеваний цнс

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
ES2058148T3 (es) * 1987-02-04 1994-11-01 Hoechst Ag N-benzopiranil-lactamas sustituidas con alquilo, procedimiento para su preparacion, su empleo, asi como preparados farmaceuticos a base de estos compuestos.
DE3703227A1 (de) * 1987-02-04 1988-08-18 Hoechst Ag Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3811017A1 (de) * 1988-03-31 1989-10-19 Hoechst Ag Ungesaettigte n-benzopyranyllactame
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate
DE3824446A1 (de) * 1988-07-19 1990-01-25 Hoechst Ag Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege
DE3827532A1 (de) * 1988-08-13 1990-03-01 Hoechst Ag 6-aroyl-substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
US5061813A (en) * 1990-04-02 1991-10-29 E. R. Squibb & Sons, Inc. Substituted cyanoimino benzopyranes
GB2242628A (en) * 1990-04-06 1991-10-09 Sandoz Ltd Asthma prophylactic use of K+ channel activators
TW244350B (de) * 1991-12-14 1995-04-01 Hoechst Ag
FI930148A (fi) * 1992-01-18 1993-07-19 Hoechst Ag Foerfarande foer enantioselektiv epoxidation av i 6-staellning substituerade kromener

Also Published As

Publication number Publication date
PE56894A1 (es) 1995-02-07
CO4230234A1 (es) 1995-10-19
GB9316111D0 (en) 1993-09-22
DE69403084T2 (de) 1997-08-14
FI960487A (fi) 1996-02-02
CN1128536A (zh) 1996-08-07
US6071938A (en) 2000-06-06
ATE152716T1 (de) 1997-05-15
NO960441D0 (no) 1996-02-02
NO960441L (no) 1996-02-02
NZ271344A (en) 1997-10-24
EP0712398A1 (de) 1996-05-22
HUT75120A (en) 1997-04-28
CA2168563C (en) 1999-09-07
IL110488A (en) 1999-08-17
DE69403084D1 (de) 1997-06-12
IL110488A0 (en) 1994-10-21
CZ281853B6 (cs) 1997-02-12
JP2871098B2 (ja) 1999-03-17
KR0175532B1 (ko) 1999-02-18
TW333532B (en) 1998-06-11
JPH08508042A (ja) 1996-08-27
PL312788A1 (en) 1996-05-13
AU7494894A (en) 1995-02-28
ECSP941140A (es) 1995-01-16
CA2168563A1 (en) 1995-02-16
US5912244A (en) 1999-06-15
EG20525A (en) 1999-06-30
EP0712398B1 (de) 1997-05-07
DK0712398T3 (da) 1997-10-27
FI960487A0 (fi) 1996-02-02
CZ33196A3 (en) 1996-05-15
ZA945774B (en) 1996-02-05
GR3023521T3 (en) 1997-08-29
ES2102870T3 (es) 1997-08-01
WO1995004730A1 (en) 1995-02-16
AU684817B2 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
MX9705590A (es) Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones que los contienen.
EG20525A (en) Benzopyrans
DE69705829T2 (de) Meta-substituierte phenylsulphonamidderivate
AU2337097A (en) Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
BG100951A (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
SG48750A1 (en) Tricyclic carbonate compounds useful for inhabition of g-protein function for treatment of proliferative diseases
CA2211522A1 (en) Novel compounds
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
AU5236293A (en) Antidepressant and antiparkinsonian compounds
FI902632A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita
FI935799A (fi) Aryylisubstituoituja heterosyklisiä yhdisteitä
CA2112061A1 (en) Alkyl substituted heterocyclic compounds
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
CA2276203A1 (en) N-(pyridinylamino)isoindolines and related compounds
GB2333294A (en) Cytokine production inhibitors
CA2155837A1 (en) Benzopyrans as potassium channel openers
DE69418715D1 (en) Erythromycinderivate
AU5334196A (en) Method for the preparation of esters of anhydroecgonine
TW349096B (en) Benzothiophene compounds, intermediates, compositions, and methods